CN116200420A - 一种高效表达眼镜王蛇抗菌肽oh-cath30的串联多拷贝重组表达载体及其应用 - Google Patents
一种高效表达眼镜王蛇抗菌肽oh-cath30的串联多拷贝重组表达载体及其应用 Download PDFInfo
- Publication number
- CN116200420A CN116200420A CN202211617849.4A CN202211617849A CN116200420A CN 116200420 A CN116200420 A CN 116200420A CN 202211617849 A CN202211617849 A CN 202211617849A CN 116200420 A CN116200420 A CN 116200420A
- Authority
- CN
- China
- Prior art keywords
- cobra
- antibacterial peptide
- vector
- expression vector
- cath30
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003910 polypeptide antibiotic agent Substances 0.000 title claims abstract description 42
- 239000013604 expression vector Substances 0.000 title claims abstract description 17
- 238000003259 recombinant expression Methods 0.000 title claims abstract description 15
- 241000272108 Ophiophagus hannah Species 0.000 title description 5
- 241000270295 Serpentes Species 0.000 claims abstract description 40
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 34
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 16
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 9
- 108020004705 Codon Proteins 0.000 claims abstract description 8
- 238000012546 transfer Methods 0.000 claims abstract description 8
- 238000005520 cutting process Methods 0.000 claims abstract description 4
- 239000013598 vector Substances 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 239000013612 plasmid Substances 0.000 claims description 13
- 238000001976 enzyme digestion Methods 0.000 claims description 9
- 238000010276 construction Methods 0.000 claims description 6
- 238000005457 optimization Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 3
- 230000002068 genetic effect Effects 0.000 claims description 3
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 2
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000010367 cloning Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 230000006801 homologous recombination Effects 0.000 claims description 2
- 238000002744 homologous recombination Methods 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 238000011027 product recovery Methods 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 230000009466 transformation Effects 0.000 claims description 2
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- 108700010070 Codon Usage Proteins 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 230000004071 biological effect Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229940092559 enterobacter aerogenes Drugs 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 108010055991 BglII endonuclease Proteins 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 108010005054 Deoxyribonuclease BamHI Proteins 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 101150045458 KEX2 gene Proteins 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000014509 cathelicidin Human genes 0.000 description 1
- 108060001132 cathelicidin Proteins 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/84—Pichia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明公开了一种高效表达眼镜王蛇抗菌肽OH‑CATH30的串联多拷贝重组表达载体及其应用。本发明将进行过密码子偏爱性优化眼镜王蛇抗菌肽基因,并将密码子优化后的成熟肽基因插入到pPICZaA载体,通过酶切酶连串联连接连到pPIC9K载体上,转入毕赤酵母中,筛选重组酵母表达菌,制备眼镜王蛇抗菌肽。本发明采用的多拷贝串联表达技术能较为有效的提高酵母表达眼镜王蛇抗菌肽的产量,并且对眼镜王蛇抗菌肽的生物活性无显著影响,安全性极高。
Description
技术领域
本发明涉及基因工程技术领域,尤其涉及一种高效表达眼镜王蛇抗菌肽OH-CATH30的串联多拷贝重组表达载体及其应用。
背景技术
眼镜王蛇抗菌肽OH-CATH30是由30个氨基酸组成的cathelicidins的截短肽,目前研究发现其对大肠杆菌(Escherichia coli)、铜绿假单胞菌(Pseudomona aeruginosa )、金黄色葡萄球菌(Staphylococcus aureus)和产气肠杆菌(Enterobacter aerogenes)等多种革兰氏阴性菌和革兰氏阳性菌均具有较好的抑菌效果。因此,眼镜王蛇抗菌肽OH-CATH30是一种非常有前景的药物候选分子,可以用来治疗各种常规抗生素耐药菌引起的感染。
目前,无论是通过化学合成或者生物合成,所获得的眼镜王蛇抗菌肽OH-CATH30产量都无法满足实际使用中的需求。本发明采用眼镜王蛇抗菌肽基因,将其通过酶切酶连形成多拷贝基因,构建酵母表达的重组质粒,建立酵母表达系统用于获取眼镜王蛇抗菌肽。
发明内容
本发明的目的是要提供一种高效表达眼镜王蛇抗菌肽的多拷贝重组表达载体及应用,采用基因工程技术,构建串联多拷贝的质粒,以毕赤酵母为宿主,成功表达多拷贝串联蛋白。
为实现上述目的,本发明采用如下技术方案:
1)根据现有的眼镜王蛇抗菌肽氨基酸序列,按照毕赤酵母对遗传密码子的偏爱性对眼镜王蛇抗菌肽基因进行密码子优化,并将密码子优化后的成熟肽基因插入到pPICZaA载体,通过酶切酶连串联连接连到pPIC9K载体上;
2)根据pPIC9K载体的序列设计上下游两条引物,进行PCR扩增,PCR产物克隆至Pmd18T载体,通过酶切酶连获得转移载体,转移载体通过单酶切,与目的载体连接,获得多拷贝数的重组表达载体,对连接产物的鉴定;
3)重组表达载体转入毕赤酵母中,筛选重组酵母表达菌;
4)对同源重组成功的毕赤酵母进行诱导表达,从而得到分泌表达的多拷贝眼镜王蛇抗菌肽蛋白;
优选的,所述的pPIC9K表达载体构建包括以下内容:pPIC9K载体的酶切及酶切产物回收;眼镜王蛇抗菌肽序列和载体的连接;连接产物的鉴定。
优选的,所述的连接产物的鉴定包括制备感受态细胞、转化反应、重组质粒提取和鉴定。
其中,所述的眼镜王蛇抗菌肽基因的核苷酸序列可以是任何一种基因的核苷酸序列。核苷酸序列是通过酵母密码子偏爱优化后的核苷酸序列。多拷贝基因中的串联拷贝数目是3个拷贝以内。
本发明选用毕赤酵母为宿主菌。毕赤酵母具有真核生物特有的蛋白高效分泌表达,翻译后修饰,因此,近年来毕赤酵母成为表达外源目的蛋白,特别是真核来源的外源蛋白的高效表达系统。
本发明对测序鉴定后的质粒酶切线性化后电转化GS115毕赤酵母感受态细胞,转化后的细胞涂布于YPD平板,挑选单克隆,对克隆进行小量发酵培养,发酵液采用SDS-PAGE分离后,以获得表达眼镜王蛇抗菌肽的发酵液蛋白。发酵液蛋白经Ni-NTA琼脂糖树脂亲和层析后,使用相应的蛋白酶进行切割,再对所得到的眼镜王蛇抗菌肽纯化。
本发明的有益效果在于:
(1)本发明采用酵母表达眼镜王蛇抗菌肽时,通过串联多拷贝的方式,将眼镜王蛇抗菌肽表达产量提高多倍。
(2)本发明采用基因工程技术,构建串联多拷贝的质粒,以毕赤酵母为宿主,成功表达多拷贝串联蛋白;本发明提供的方法具有通用性强、表达效率较高、具有生物活性、成本低、易规模化生产等优点。
(3)本发明相较于眼镜王蛇抗菌肽的单拷贝表达,使得眼镜王蛇抗菌肽的产量提高2-4倍,且并未增加生产工序,生产成本基本与单拷贝表达持平。
附图说明
图1为眼镜王蛇抗菌肽单拷贝基因全合成图;
图2为二拷贝载体的构建的方案设计图;
图3为三拷贝载体的构建的方案设计图。
图4为抑菌活性实验结果图,F为对肺炎克雷伯菌抑菌效果的抑菌圈,J为对金黄色葡萄球菌的抑菌圈,编号5、6、7代表3组发酵罐号,发酵罐号后的标记为诱导表达培养时间,例5-84h代表5号发酵罐表达84小时的上清液的抑菌实验结果。
具体实施方式
为了使本发明所述的内容更加便于理解,下面结合具体实施方式对本发明所述的技术方案做进一步的说明,但是本发明不仅限于此。
蛋白胨Peptone、硫酸铵、甲醇、琼脂、葡萄糖、磷酸钾缓冲液、甘油、山梨醇购于国药集团化学试剂有限公司;
YNB购于北京索莱宝科技有限公司;
酵母提取物Yeast extract购于OXOID公司;
细菌菌株购自中国普通微生物菌种保藏管理中心。
除非特别指明,本发明以下实施例所用的试剂均为分析纯试剂,且可从常规渠道商购获得。
本发明中的YPDS培养基的配制: 酵母提取物Yeast extract 1%,蛋白胨Peptone2%, 葡萄糖 2%,固体培养基则添加琼脂粉 2%。
本发明中的BMMY培养基的配制:
酵母提取物Yeast extract 1%,蛋白胨Peptone 2%, 磷酸钾缓冲液(pH6.0)100mmol/L, YNB 1.34%, 硫酸铵 1%,加水配置成100ml的培养基。毕赤酵母诱导表达培养基,YNB过滤除菌。摇瓶培养时每24小时之后加入0.5%的甲醇诱导,一般诱导72小时。
BMGY培养基的配制:
酵母提取物Yeast extract 1%,蛋白胨Peptone 2%, 磷酸钾缓冲液(pH6.0)100mmol/L, YNB 1.34%, 硫酸铵 1%,甘油 1%,加水配置成100ml的培养基。
山梨醇培养基的配制
取18.217g山梨醇溶于100ml无菌水中配置成的1M山梨醇培养基,0.22μm滤膜过滤除菌。
实施例1
1.眼镜王蛇抗菌肽单拷贝基因的全合成
根据现有的眼镜王蛇抗菌肽氨基酸序列,按照毕赤酵母对遗传密码子的偏爱性对眼镜王蛇抗菌肽基因进行密码子优化,优化为酵母菌偏爱的密码子基因片段,全基因合成并插入到pPICZaA载体上。
GAGAAGAGAAAGTTCTTTAAGAAGTTGAAGAACTCTGTTAGAAAGAAGGCTAAGAAGTTCTTCAAGAAGCCAAGAGTTATTGGTGTTTCTATTCCATTCTAA
具体操作为pPICZaA载体的KEX2酶切位点之后到TGA之间的序列全部删除,用已经密码子偏爱性优化后的眼镜王蛇抗菌肽基因替换,末尾加TAA终止,再连接载体TGA之后的序列。眼镜王蛇抗菌肽单拷贝基因全合成图如图1所示。
实施例2
pPIC9K表达载体的构建
采用限制性内切酶Xcm I、AgeI分别双酶切pPICZaA、pPIC9K载体。pPICZaA载体切下的小片段即胶回收后的产物与双酶切的pPIC9K载体用T4 DNA连接酶连接,转入感受态E.coli DH5α。挑选单克隆,采用PCR技术及测序进行质粒阳性鉴定。
实施例3
多拷贝载体的构建
1)根据pPIC9K载体的序列设计了两条引物,
5’AOXPF: 5’CGGGATCCAACATCCAAAGACGAaaggttgaa (BamH I);
3’AOXTR: 5’GCAGATCTTAACTGTGATAAACTACC(Bgl II).
以1拷贝质粒为模板,用PfuDNA聚合酶进行PCR扩增,PCR产物克隆至pMD18T载体中测序鉴定。
2)用BglII内切酶将1拷贝质粒酶切分别回收大小7000bp和2400bp左右的片段,并使用CIAP去磷酸化,-20℃保存备用。
3)使用BamHI和Bgl II双酶切含1拷贝表达框pMD18T的质粒,回收1拷贝表达框片段,连接到Bgl II酶切并去除磷酸化的质粒2400bp左右的小片段中,转化大肠杆菌感受态,获得转移载体,BamHI内切酶和Bgl II内切酶是同尾酶。
4)转移载体使用Bgl II酶切回收与Bgl II酶切的质粒7000bp左右的大片段连接,转化大肠杆菌感受态,用Bgl II酶切鉴定,即可获得较转移载体多一拷贝数的表达载体。
实施例4
重组酵母菌的诱导表达及检测
1)将80ul酵母感受态细胞和5µg Sal I线性化后的质粒混合后转移至电转杯中,冰浴5min。电击后立刻向电转杯加入200ul山梨醇培养基,混均后,将全部菌液涂布在MD固体培养基平板上,在28℃ 培养3 d。
2)挑取含有表达质粒的毕赤酵母单菌落接入BMGY培养基,30℃,280rpm振荡培养,培养菌体浓度至=2 ~ 6,更换培养基为BMMY培养基,每隔24h,补加终浓度为0 .5%的甲醇。发酵120h,收集的上清液,通过SDS-PAGE凝胶分析。分析结果显示酵母成功表达蛋白,且不同拷贝数间蛋白量无明显差异。
实施例5
多拷贝表达产量与单拷贝表达产量的比较
取部分上清进行SDS-PAGE检测,以此衡量其蛋白产量。发酵上清经过HPLC纯化,然后经质谱鉴定,得到纯品,用微量BCA蛋白定量分析试剂盒测其浓度。不同拷贝数眼镜王蛇抗菌肽产量对比如下表1:
表1不同拷贝数眼镜王蛇抗菌肽产量对比
拷贝数 | 1 | 2 | 3 |
产量 | 27 mg/L | 44 mg/L | 65 mg/L |
实施例6
用25ml LB液体培养基培养肺炎克雷伯菌和金黄色葡萄球菌,37℃180rpm过夜培养后,再转接到25ml LB液体培养基中,同样条件培养1 .5h-2h,OD值在0 .4-0 .6之间,取30ul菌液到100mlLB冷却至不烫手的固体培养基中,混匀后倒平板;待其凝固后将牛津杯放在表面,分别加入50ul重组表达的眼镜王蛇抗菌肽样品,同时用pPIC9k空载体做空白对照组,37℃过夜培养后测定其透明圈的大小,一共做3组实验。得出重组表达的眼镜王蛇抗菌肽对金黄色葡萄球菌有明显抑制效果。
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。
Claims (4)
1.一种高效表达眼镜王蛇抗菌肽OH-CATH30的串联多拷贝重组表达载体及其应用,具体步骤包括:
1)根据现有的眼镜王蛇抗菌肽氨基酸序列,按照毕赤酵母对遗传密码子的偏爱性对眼镜王蛇抗菌肽基因进行密码子优化,并将密码子优化后的成熟肽基因插入到pPICZaA载体,通过酶切酶连串联连接连到pPIC9K载体上;
2)根据pPIC9K载体的序列设计上下游两条引物,进行PCR扩增,PCR产物克隆至Pmd18T载体,通过酶切酶连获得转移载体,转移载体通过单酶切,与目的载体连接,获得多拷贝数的重组表达载体;
3)重组表达载体转入毕赤酵母中,筛选重组酵母表达菌;
4)对同源重组成功的毕赤酵母进行诱导表达,从而得到分泌表达的多拷贝眼镜王蛇抗菌肽蛋白。
2.根据权利要求1所述的一种高效表达眼镜王蛇抗菌肽OH-CATH30的串联多拷贝重组表达载体及其应用,其特征在于,所述的pPIC9K表达载体构建包括以下内容:pPIC9K载体的酶切及酶切产物回收;眼镜王蛇抗菌肽序列和载体的连接;连接产物的鉴定。
3.根据权利要求2所述的一种高效表达眼镜王蛇抗菌肽OH-CATH30的串联多拷贝重组表达载体及其应用,其特征在于,所述的连接产物的鉴定包括制备感受态细胞、转化反应、重组质粒提取和鉴定。
4.根据权利要求1所述的一种高效表达眼镜王蛇抗菌肽OH-CATH30的串联多拷贝重组表达载体及其应用,其特征在于,所述的多拷贝眼镜王蛇抗菌肽基因中的串联拷贝数目是3个拷贝以内。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211617849.4A CN116200420A (zh) | 2022-12-15 | 2022-12-15 | 一种高效表达眼镜王蛇抗菌肽oh-cath30的串联多拷贝重组表达载体及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211617849.4A CN116200420A (zh) | 2022-12-15 | 2022-12-15 | 一种高效表达眼镜王蛇抗菌肽oh-cath30的串联多拷贝重组表达载体及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116200420A true CN116200420A (zh) | 2023-06-02 |
Family
ID=86515230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211617849.4A Pending CN116200420A (zh) | 2022-12-15 | 2022-12-15 | 一种高效表达眼镜王蛇抗菌肽oh-cath30的串联多拷贝重组表达载体及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116200420A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006089455A1 (fr) * | 2005-02-22 | 2006-08-31 | Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences | Protéine de fusion antitumorale de ciblage comprenant la protéine adénovirale e4orf4 |
CN102409003A (zh) * | 2010-09-26 | 2012-04-11 | 中国农业科学院饲料研究所 | 多拷贝高效表达重组菌丝霉素的毕赤酵母 |
CN104031935A (zh) * | 2014-05-23 | 2014-09-10 | 宁波大学 | 大黄鱼肝表达抗菌肽leap-2c在毕赤酵母中的胞内表达方法 |
CN104829703A (zh) * | 2015-03-23 | 2015-08-12 | 广东药学院 | 一种重组金环蛇抗菌肽Cath-BF34及其高效制备方法 |
CN113980112A (zh) * | 2021-11-25 | 2022-01-28 | 中国科学院昆明动物研究所 | 一种眼镜王蛇抗菌肽oh-cath30的表达载体和表达产物及其构建制备方法 |
CN115558019A (zh) * | 2022-04-13 | 2023-01-03 | 江苏亢钧生物科技有限公司 | 一种眼镜王蛇抗菌肽oh-cath30的基因工程制备方法 |
CN116555319A (zh) * | 2023-05-09 | 2023-08-08 | 江苏亢钧生物科技有限公司 | 多拷贝整合与高密度发酵合成短吻鳄抗菌肽am-cath的方法 |
-
2022
- 2022-12-15 CN CN202211617849.4A patent/CN116200420A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006089455A1 (fr) * | 2005-02-22 | 2006-08-31 | Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences | Protéine de fusion antitumorale de ciblage comprenant la protéine adénovirale e4orf4 |
CN102409003A (zh) * | 2010-09-26 | 2012-04-11 | 中国农业科学院饲料研究所 | 多拷贝高效表达重组菌丝霉素的毕赤酵母 |
CN104031935A (zh) * | 2014-05-23 | 2014-09-10 | 宁波大学 | 大黄鱼肝表达抗菌肽leap-2c在毕赤酵母中的胞内表达方法 |
CN104829703A (zh) * | 2015-03-23 | 2015-08-12 | 广东药学院 | 一种重组金环蛇抗菌肽Cath-BF34及其高效制备方法 |
CN113980112A (zh) * | 2021-11-25 | 2022-01-28 | 中国科学院昆明动物研究所 | 一种眼镜王蛇抗菌肽oh-cath30的表达载体和表达产物及其构建制备方法 |
CN115558019A (zh) * | 2022-04-13 | 2023-01-03 | 江苏亢钧生物科技有限公司 | 一种眼镜王蛇抗菌肽oh-cath30的基因工程制备方法 |
CN116555319A (zh) * | 2023-05-09 | 2023-08-08 | 江苏亢钧生物科技有限公司 | 多拷贝整合与高密度发酵合成短吻鳄抗菌肽am-cath的方法 |
Non-Patent Citations (2)
Title |
---|
孔凡红等: "生物抗菌肽毕赤酵母表达系统研究进展", 中国病原生物学杂志, 30 September 2009 (2009-09-30), pages 700 * |
祁丽等: "抗菌肽多基因表达技术与策略", 黑龙江畜牧兽医, 17 August 2016 (2016-08-17), pages 52 - 56 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107245494B (zh) | Aβ42在大肠杆菌中的高效可溶性表达及纯化方法 | |
CN109825484B (zh) | 玉米赤霉烯酮水解酶zhd101突变体及利用该突变体水解玉米赤霉烯酮的方法 | |
US11053505B2 (en) | Cleavable fusion tag for protein overexpression and purification | |
CN111278852A (zh) | 重组欧氏杆菌天冬酰胺酶的生产方法 | |
CN102839165A (zh) | 基因突变型重组蛋白酶k及其工业化生产方法 | |
WO2023221787A1 (zh) | 重组i型胶原蛋白毕赤酵母工程菌及其构建方法与应用 | |
CN116555319A (zh) | 多拷贝整合与高密度发酵合成短吻鳄抗菌肽am-cath的方法 | |
CN107058363B (zh) | 基于淀粉样蛋白实现小分子肽类高效分泌表达的方法及其应用 | |
CN106834252B (zh) | 一种高稳定型MazF突变体及其应用 | |
CN107723287B (zh) | 一种增强丝蛋白生产制备的表达系统 | |
CN116200420A (zh) | 一种高效表达眼镜王蛇抗菌肽oh-cath30的串联多拷贝重组表达载体及其应用 | |
CN102827860B (zh) | 一种用于重组蛋白分泌型表达的双基因突变大肠杆菌的构建方法 | |
CN112795587B (zh) | 一株产表面活性素的大肠杆菌工程菌及其构建方法与应用 | |
CN110819609B (zh) | 一种热稳定性提高的突变脂肪酶及其制备方法与应用 | |
CN116656516A (zh) | 基于两拷贝基因筛选高表达眼镜王蛇联合肽damp4-oh30重组菌株的方法 | |
CN113056554A (zh) | 重组酵母细胞 | |
CN104846001A (zh) | 一种外源蛋白原核分泌表达系统及其应用 | |
CN116854792B (zh) | 突变型α-factor信号肽及其编码基因、表达载体和应用 | |
CN108179142A (zh) | 一种新的IgA蛋白酶及其制备方法和应用 | |
CN108359686A (zh) | 融合标签NusA在大肠杆菌表达PLCG2蛋白中的应用 | |
CN107857801B (zh) | 一种可用于提高分泌效率的信号肽及其应用 | |
CN115960851A (zh) | 内含肽Wir Gp071变体、编码基因及其在制备九肽-1中的应用 | |
US20150037842A1 (en) | Modified bacterial cell | |
CN116102628A (zh) | 活性聚集肽及其应用 | |
US20220002353A1 (en) | Dextran affinity tag and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |